Related by context. All words. (Click for frequent words.) 56 Chemokine Therapeutics 56 Avila Therapeutics 55 EGEN 55 Regado Biosciences 55 Enanta Pharmaceuticals 55 Nasdaq ONXX 54 Syndax 54 FOLOTYN ® 54 Isotechnika Pharma 54 VentiRx 54 R sorafenib tablets 54 Celator 54 Phenomix Corporation 54 zanolimumab 53 vaccines oncolytic virus 53 Myocet 53 Kosan dependence 53 Nasdaq ENZN 53 Catabasis 52 IRX Therapeutics 52 oncolytic virus therapies 52 Gemin X 52 oncology therapeutics 52 novel therapeutic antibodies 52 Harry Palmin President 52 docetaxel Taxotere R 52 L BLP# 52 Pervasis 52 Cancer Immunotherapy 52 ZFP Therapeutics 52 enzastaurin 52 StromaCel Inc. 52 Tolerx 51 Tragara Pharmaceuticals Inc. 51 GammaCan 51 Zacharon 51 Regulus Therapeutics 51 CDRD 51 commercialize deforolimus 51 Arno Therapeutics 51 Semafore Pharmaceuticals 51 Numoda 51 Teva Neuroscience 51 GVAX ® 51 PHT Corporation 51 Surface Logix 51 XTLbio 51 SuperAntibody 51 Romidepsin 51 evaluating tivozanib 51 Onyx Pharmaceuticals Announces 51 Insegia 51 oral JAK#/JAK# inhibitor 50 isoform selective 50 ProLindac TM 50 Bayer HealthCare AG 50 Neogenix 50 ALN TTR 50 PDX pralatrexate 50 Etubics 50 TESARO 50 Hollis Eden 50 Opexa 50 StemEx R 50 Genitope Corporation 50 alvespimycin 50 XL# XL# XL# 50 Expression Pathology 50 Pervasis Therapeutics 50 EyeGate Pharma 50 TetraLogic 50 Glufosfamide 50 iBIO Institute 50 afatinib 50 XL# XL# 50 Neil K. Warma 50 ALN PCS 50 Galenea 50 Immunotherapeutic 50 Oxxon 50 SEQUENOM 50 Myelodysplastic Syndromes Foundation 50 Diatos 50 oral deforolimus 50 Sunesis Pharmaceuticals Inc. 50 FoldRx 50 Ziopharm Oncology 50 IMA# 49 sunitinib malate 49 Epiphany Biosciences 49 ARIUS 49 Annamycin 49 BioMS Medical 49 ThermoDox R 49 Novella Clinical 49 sapacitabine CYC# 49 Pfizer Ophthalmics 49 ZLB Behring 49 CD# CEA 49 Genentech BioOncology 49 Bionovo 49 Cyntellect 49 ZARS Pharma 49 CoLucid 49 DPX Survivac 49 Neuraltus 49 AdvanSource 49 Surfaxin LS 49 trastuzumab DM1 T DM1 49 forodesine 49 tubulin inhibitor 49 Afferent Pharmaceuticals 49 ARRY # 49 NASDAQ LIPD 49 Chimigen TM 49 Predictive Biosciences 49 MyVax ® 49 Halozyme Therapeutics 49 adecatumumab MT# 49 Vaccinex 49 Canvaxin 49 Ascenta Therapeutics 49 Aphton 49 enGene 49 NP2 Enkephalin 49 MultiCell Technologies 49 Neotropix 49 pralatrexate injection folate analogue 48 Progenics Pharmaceuticals 48 Mersana 48 initiated Phase 1b 48 Relypsa 48 Capsulution 48 lapatinib Tykerb 48 GED aPC 48 IL# PE#QQR 48 ALN VSP 48 ZACTIMA 48 taribavirin 48 cancer immunotherapies 48 Nereus Pharmaceuticals 48 tiapamil 48 ThermoDox ® clinical 48 deforolimus 48 BioCentury Future Leaders 48 Oncolytics Biotech Inc. 48 antiangiogenesis therapies 48 Stemedica 48 plasma protein biotherapeutics 48 THR beta agonist 48 Ipsogen 48 velafermin 48 autoimmune indications 48 CYT# potent vascular disrupting 48 ARCA biopharma 48 myeloproliferative disorders 48 Sernova 48 BrachySil TM 48 Cara Therapeutics 48 Bicifadine 48 Selective Electrochemical Tumor Ablation 48 NexGenix 48 BCIRG 48 Antisense Pharma 48 talactoferrin 48 Archexin 48 PKC# 48 Ph.D. MD hc 48 Provectus Pharmaceuticals 48 Oncolin 48 vernakalant oral 48 entinostat 48 StaphVAX R 48 refractory chronic lymphocytic 48 MMRF 48 ALN HPN 48 HCD# [002] 48 Omacetaxine 48 Tectin TM 48 ONCONASE R 48 Revotar 48 targeted radiotherapeutic 48 modified glutathione analog 48 telomerase therapeutic 48 predictive toxicology 48 Phase #b/#a clinical 48 rALLy clinical trial 48 ERYtech Pharma 48 Elotuzumab 48 rxRNA 48 ELACYT 48 Daclizumab 48 Enanta 48 Virulizin R 48 Protalex Inc. 48 Panzem R 48 Proxinium TM 48 Intellect Neurosciences 48 CRLX# 47 lintuzumab SGN 47 ProChon 47 Azedra TM 47 EOquin TM 47 investigational therapies 47 PharmaVentures 47 Nexavar ® 47 Cmed 47 Ambit Biosciences 47 Ambrx 47 farletuzumab 47 GRN# 47 ® bortezomib 47 CHDI Foundation 47 Pharmatech Oncology 47 OHR/AVR# 47 sorafenib tablets 47 HGS# 47 Logical Therapeutics 47 Clinsys Clinical Research 47 invivodata 47 investigational monoclonal antibody 47 Tumour Vascular Disrupting Agent 47 omacetaxine 47 Sulonex TM 47 Intarcia Therapeutics Inc. 47 Vicinium TM 47 NovaBay Aganocide compounds 47 OncoGel 47 Endo Pharmaceuticals 47 KNS # 47 elotuzumab 47 Idenix Pharmaceuticals 47 Zemiva TM Trofex TM 47 Aflibercept 47 ADVEXIN p# therapy 47 rheumatoid arthritis Roche PEGASYS 47 Sopherion 47 relapsed multiple myeloma 47 GATTEX TM 47 Initiate Phase II 47 PNT# 47 Exherin 47 CCX# B 47 refractory metastatic 47 telomerase inhibitor drug 47 cilengitide 47 Nektar pulmonary 47 PEG SN# 47 FOLFIRI chemotherapy 47 SUCCEED trial 47 Bezielle 47 Memgen 47 EndoTAG TM -1 47 IMiDs 47 metaglidasen 47 Regeneron Pharma 47 Celladon Corporation 47 Phase Ib II 47 CardioVascular BioTherapeutics 47 delay bone metastases 47 MAGE A3 ASCI 47 CoNCERT 47 vosaroxin 47 EnVivo Pharmaceuticals 47 IAP inhibitors 47 multicenter Phase II 47 axitinib 47 Ixempra 47 Zybrestat 47 neratinib 47 MOZOBIL 47 MaRS Innovation 47 Nicole Onetto MD 47 FOLFOX6 chemotherapy regimen 47 BASi 47 BioNumerik 47 Research MJFF 47 InVivo Therapeutics Corporation 47 SCIREX 47 Gemzar ® 46 Personalized Immunotherapy 46 Combination REOLYSIN R 46 Intarcia 46 IgG1 monoclonal antibody 46 Freedom Meditech 46 Targeted Chemotherapy 46 CoFactor 46 ALS TDI 46 eritoran 46 AviaraDx 46 Amarantus 46 Howard Fillit MD 46 Intravenous CP 46 GVAX R 46 Semafore 46 PI3K/Akt pathway inhibitor 46 palifosfamide Zymafos TM 46 Allovectin 7 R 46 selective immunoproteasome inhibitor 46 oral proteasome inhibitor 46 investigational immunotherapy 46 BIO Windhover 46 oral antiviral 46 MedNet Solutions 46 YONDELIS 46 Allovectin 7 ® 46 CAMPATH 46 Aplidin 46 Imedex 46 paclitaxel Taxol ® 46 BioFinance 46 LymphoStat B TM 46 Solazed TM 46 Genizon 46 Lightlake Therapeutics 46 CombinatoRx 46 Nanobody 46 Ceregene 46 AEG# 46 ongoing Phase IIIb 46 Avicena 46 Lpath 46 personalized immunotherapy 46 Allovectin 7 46 JAK inhibitor 46 REOLYSIN ® 46 Odyssey Thera 46 R bortezomib 46 anticancer therapies 46 ImmunoGen TAP technology 46 Otonomy 46 OVATION Pharmaceuticals Inc. 46 EmergingMed 46 Panzem R NCD 46 product platforms AZX# 46 ImmunoCellular Therapeutics 46 Bioral Amphotericin B 46 Metabolon 46 HGS ETR2 46 G#DT 46 Development OOPD 46 oral picoplatin 46 BioAlliance Pharma 46 Mersana Therapeutics Inc. 46 Endovasc 46 Project Boveri Find 46 Thelin TM 46 ZK EPO 46 PLK1 SNALP 46 Aureus Pharma 46 InVasc 46 MAXY G# 46 Pluristem Therapeutics 46 Sentrx 46 MEK inhibitors 46 Exelixis XL# 46 Phase Ib clinical 46 ZEVALIN ® 46 PhaseBio 46 Innate Pharma 46 MEK inhibitor RDEA# 46 Exco InTouch 46 Phase III Pivotal 46 MGN# 46 CRMD# 46 romidepsin 46 Marillion Pharmaceuticals 46 Quinnova 46 Optimer Pharmaceuticals 46 relapsed refractory multiple myeloma 46 pemetrexed Alimta 46 Thiovir 46 Virulizin ® 46 Paramount BioSciences 46 oral ridaforolimus 46 NACHC 46 Sirion Therapeutics Inc. 46 Jevtana 46 Celldex 46 oral prodrug 46 Trofex TM 45 PAC G#P 45 initiated Phase Ib 45 BioCentury NewsMakers 45 AAG geldanamycin analog 45 KYTHERA 45 Deltanoid 45 TRAIL receptor antibodies 45 GVAX Pancreas Vaccine 45 REOLYSIN R 45 CIHR 45 Biopharmaceutical Industry 45 Exherin TM 45 Acumen BioFin 45 Abiraterone acetate 45 Antibody Therapeutics 45 FavId 45 FzioMed 45 www.boehringer ingelheim.com 45 AKT inhibitor 45 Bioheart Inc. 45 Talactoferrin 45 Multiple Myeloma Research 45 refractory PTCL 45 fund BioSante LibiGel 45 evaluating satraplatin 45 radiation sensitizer 45 InVivo Therapeutics 45 Neulasta ® 45 Alocrest 45 PNP inhibitor 45 pertuzumab 45 Apitope 45 TASKi2 45 Samaritan Pharmaceuticals 45 Berlex Biosciences 45 Alder Biopharmaceuticals 45 CSL Behring 45 Panzem NCD 45 CR# vcMMAE 45 KRN# 45 oral Azacitidine 45 Pacific Biometrics 45 www.michaeljfox.org 45 Syllego system 45 Anaphore 45 microsphere therapy 45 Fresenius Biotech 45 TransVax ™ 45 Budesonide MMX 45 BRIM2 45 botanical therapeutics 45 Revlimid lenalidomide 45 Phytomedics Inc. 45 class mGluR5 inhibitor 45 AdMeTech Foundation 45 OMP #R# 45 TFChem licenses 45 Eurand 45 SECURE THE FUTURE 45 drug GAP #B# 45 Nasdaq DVAX 45 CCR5 mAb 45 RNAi Therapeutic 45 TCWF 45 Biotest AG 45 Ikaria Holdings Inc. 45 BioContact Quebec 45 Neuradiab 45 PARI Pharma 45 Elan NanoCrystal 45 Allovectin 7 r 45 TNFerade TM 45 Friedreich Ataxia 45 Vandetanib 45 tremelimumab 45 Phase #/#a trial 45 Vitaxin 45 Brentuximab Vedotin SGN 45 NOVAVAX 45 Aegis Therapeutics 45 PRTX 45 ProNAi 45 Troxatyl 45 Zemiva TM 45 huC# DM4 45 Foundation MMRF 45 phase IIa clinical 45 SECTA therapy 45 velafermin belinostat 45 non nucleoside polymerase 45 OncoVEX 45 OncoVEX GM CSF 45 APPRAISE 45 CFFT 45 recurrent metastatic ovarian cancer 45 PSMA ADC 45 Trellis Bioscience 45 ONCASPAR 45 lintuzumab 45 miRagen 45 IMC #B 45 proprietary capillary aerosolization 45 Pharmalicensing 45 eniluracil 45 Panzem 45 adecatumumab 45 Guanilib 44 olaparib 44 TREAT NMD 44 multiple myeloma MM 44 Onalta 44 Civacir 44 XL# anticancer compounds 44 cMET 44 omega interferon 44 Litx 44 hematological malignancies 44 Hedgehog Pathway Inhibitor 44 Amrubicin 44 EGRIFTA TM 44 PharmaNova 44 Dr. Dreismann 44 glufosfamide 44 Hepatocellular Carcinoma HCC 44 LEUKINE 44 interferon gamma 1b 44 mitogen activated ERK kinase 44 Azedra 44 obatoclax 44 RNAi therapeutic 44 PAREXEL 44 DDW ® 44 LibiGel Phase III 44 Consortium MMRC 44 Ceflatonin 44 ongoing Phase 1b 44 Epigenomics 44 BIO Investor 44 oral taxane 44 lumiliximab 44 Carfilzomib 44 FRSQ 44 Celladon 44 Inovio Pharmaceuticals 44 ridaforolimus 44 IDRI 44 Dacogen injection 44 HCV protease inhibitor 44 Xennex 44 Azedra ™ 44 MEK inhibitor 44 Golimumab 44 MyVax R 44 Apaziquone 44 sodium thiosulfate STS 44 Alnylam #x# 44 Enhanze 44 HspE7 44 BENLYSTA ® 44 CoDa Therapeutics 44 drug conjugate 44 HER2 positive metastatic breast 44 OMAPRO 44 antisense drug 44 TKM PLK1 44 Imprime PGG 44 Chemophase 44 MT# MEDI 44 CA4P 44 BLP# Liposome Vaccine 44 antibody MAb 44 Tesetaxel 44 Tivozanib 44 mocetinostat MGCD# 44 GaBio 44 refractory indolent non 44 XL# XL# XL# XL# 44 Curemark 44 Reolysin 44 GenSpera 44 Cloretazine ® 44 Sirnaomics 44 AMCP 44 BioAlliance 44 leukemia lymphoma Hodgkin 44 picoplatin 44 Sym# 44 mertansine 44 Genasense ® 44 celgosivir 44 NACDD 44 iOWH 44 Juvaris 44 R#/MEM # 44 OMP #M# 44 PXD# 44 Mara Aspinall 44 Xeloda ® 44 CEQ# 44 OXi# 44 Windhover Therapeutic Area 44 Listeria vaccine 44 Tarvacin TM 44 sarcoma melanoma 44 dacetuzumab SGN 44 ISA# [002] 44 BioLineRx 44 TOCOSOL Paclitaxel 44 INCB# [001] 44 phase IIb clinical 44 mapatumumab 44 ISTODAX ® 44 ImQuest 44 J.P. Morgan Healthcare 44 ACAPODENE TM 44 Biogen Idec NASDAQ BIIB 44 Akaza Research 44 candidate AQ4N 44 CBLC# 44 registrational 44 Viramidine 44 ASA# 44 ExL Pharma 44 systemic RNAi therapeutic 44 NPC 1C 44 platinum chemotherapeutic 44 lorvotuzumab mertansine 44 pralatrexate 44 Avidex 44 gastrointestinal GVHD 44 JAK2 inhibitor 44 refractory AML 44 Wellstat Therapeutics 44 ImmuneRegen BioSciences 44 OvaRex R 44 Nabi Biopharmaceuticals 43 GTC recombinant human 43 otelixizumab 43 Tod Woolf Ph.D. 43 Addex Pharmaceuticals SWISS ADXN 43 Hsp# Inhibitor 43 Vidaza ® 43 Sage Bionetworks 43 Abeome 43 novel anticancer 43 Cloretazine R 43 Curaxin 43 HGS ETR1 43 ATL# [001] 43 BioScale 43 Tarceva TM 43 ixabepilone 43 ganetespib 43 UVIDEM 43 Cintredekin Besudotox 43 ritonavir boosted danoprevir 43 Regenicin 43 MetaMiner 43 #I TM# 43 custirsen 43 cetuximab Erbitux 43 NeoLipid R 43 tanespimycin 43 BIIR 43 Health Research CIHR 43 Stemgent 43 Pivotal Phase III 43 Circ Pharma 43 Adeona Pharmaceuticals 43 histone deacetylase inhibitor 43 dacetuzumab 43 ISIS # 43 TRISENOX 43 MD Moross Institute 43 Proellex TM 43 bevacizumab Avastin ® 43 MaxCyte 43 TASKi3 43 visit www.cff.org 43 AAIPharma 43 iPierian 43 Needham Biotechnology 43 Aurexis 43 vorinostat 43 ACTEMRA TM 43 DAVANAT 43 MPS VI 43 Ramoplanin 43 JAK1 43 RGB # 43 ofatumumab 43 MediVas 43 Vical Incorporated 43 liposomal formulation 43 HGS ETR1 mapatumumab 43 Phase Ib 43 oral mTOR inhibitor 43 HuMax EGFr 43 Sorrento Therapeutics 43 SAR# [004] 43 fluorinated carbohydrate mimics 43 Gentel Biosciences 43 AtCor 43 MGCD# [001] 43 FNIH 43 Caring Ambassadors 43 advanced carcinoid 43 Gliknik 43 Nicholas Landekic President 43 RhuDex ® 43 Symphogen 43 RNAi therapeutics 43 registrational trial 43 Sidney Kimmel Cancer 43 HuMax CD4 43 Celleration 43 Ketotransdel 43 refractory cutaneous T 43 Belinostat 43 perifosine 43 visit www.metlife.org 43 ASONEP 43 Perceptronix 43 MEK Inhibitor 43 PEG PAL 43 belinostat 43 ECTRIMS 43 Sequella 43 BIO InvestorForum 43 BioMarck 43 Dose Escalation 43 Voicebrook 43 ASH Annual Meeting 43 EMD Biosciences Inc. 43 ThermoDox ® 43 carfilzomib 43 BioPharma 43 ONTAK 43 Onco TCS 43 BEMA TM Fentanyl 43 bardoxolone 43 aTyr Pharma 43 VIVALIS 43 bortezomib Velcade R 43 Upcoming Investor 43 Selective Internal 43 Pancreatic Cancer 43 sorafenib Nexavar ® 43 Nexavar 43 BRAF inhibitor 43 PEG Interferon lambda 43 Xcelience 43 phase IIb III 43 biopharmaceuticals 43 depsipeptide 43 recurrent NSCLC 43 DermaVir Patch 43 non nucleoside HCV 43 MDV# 43 Calmare Therapy Treatment 43 imetelstat GRN#L 43 Windhover Conferences 43 Tarvacin 43 Tyrima 43 elacytarabine 43 NVA# 43 VEGF Trap 42 ponatinib 42 Phase 1b trial 42 ALS TDF 42 refractory CLL 42 metastatic melanoma 42 Endosense 42 Vivecon 42 Duane DeSisto 42 TLK# 42 ASGCT 42 Lovaxin C 42 telaprevir VX 42 Annual BIO 42 metastatic GIST 42 angioedema indications 42 Pluristem 42 Clolar ® 42 Tetraphase 42 alfa 2a 42 Biotech Industry 42 TELINTRA 42 Promega Corporation 42 R Bortezomib 42 Eureka Genomics 42 AQ4N 42 COU AA 42 COSHAR Foundation 42 galiximab 42 Atiprimod 42 GMX# 42 Phase IIIb clinical 42 BR.# 42 subcutaneous formulation 42 OvaRex ® MAb 42 MGd 42 AeroLEF TM 42 Phase #b/#a 42 PrevOnco 42 Orchid BioSciences 42 Genome Quebec 42 GATTEX ® 42 tesmilifene 42 Cotara 42 Restanza 42 ASGT 42 CINTREDEKIN BESUDOTOX 42 Oncolytics 42 Fludara ® 42 Phase Ib clinical trials 42 pulmonary fibrosis PF 42 Aurora kinase inhibitor 42 encapsulates siRNAs 42 Adaptive Clinical Trials 42 CureDuchenne 42 ADVEXIN 42 Meditrina Pharmaceuticals 42 Kahalalide F 42 Epothilones 42 bioinnovation 42 Viral Immunotherapy platform 42 CORLUX CORT # 42 Phase IIb III 42 demonstrated antitumor activity 42 T2 Biosystems 42 BCAN 42 SANUWAVE 42 Cambridge Healthtech Institute 42 IMP# 42 StemEx 42 Sudhir Agrawal D.Phil 42 Locteron ® 42 ALN TTR# 42 LBH# 42 Evotec AG 42 PrevOnco ™ 42 Dr. Dov Tamarkin 42 Genedata 42 GRNVAC1 42 iBIO 42 APOPTONE 42 pancreatic prostate 42 initiate Phase 1b 42 SNALP technology 42 docetaxel Taxotere ® 42 CDK cyclin dependent 42 aflibercept VEGF Trap 42 EKR 42 oncology indications 42 Aptivus ® 42 Phase IIb clinical trials 42 Protexia ® 42 Alpharadin 42 VEGFR2 inhibitor 42 Neuradiab TM 42 Sigma Tau Pharmaceuticals 42 Inhalation Solution 42 carcinoma HCC 42 oncolytic virus 42 phase IIb 42 aflibercept 42 visit www.lupus.org 42 candidates bavituximab 42 anticancer compounds 42 ApoB SNALP 42 Trofex 42 amrubicin 42 BioPharm 42 FOLOTYN 42 Aurora kinase 42 NPSF 42 TACI Ig 42 Corporation NASDAQ PRXL 42 MacroGenics 42 HuCAL GOLD ® 42 Sapacitabine 42 Exelixis compounds 42 pradefovir 42 Li Fraumeni Syndrome 42 OneMedPlace 42 Delcath PHP System 42 #D#C# 42 sapacitabine 42 Girindus 42 ARVO 42 Targretin 41 Amplimexon 41 ALS Amyotrophic Lateral Sclerosis 41 MorphoSys AG FSE MOR 41 metastatic HRPC 41 Sandostatin LAR Depot 41 anticancer compound 41 phase Ib 41 refractory Hodgkin lymphoma 41 CUDC 41 Ixabepilone 41 BCBSM Foundation 41 FDC Windhover 41 Meso Foundation 41 cediranib 41 multicenter Phase 41 BCX# 41 Acurian 41 Nabriva Therapeutics 41 Silence Therapeutics plc 41 Phase 2a clinical trials 41 Scil Proteins 41 Diagnostic HYBRIDS 41 VASTox 41 huN# DM1 41 NB S# 41 synthetic retinoid 41 ThermoDox 41 Islet Transplantation 41 DSRTF 41 EuroMedtech ™ 41 PRECISE Trial 41 BayBio 41 novel VDA molecule 41 humanized anti 41 WLSA Convergence Summit 41 eculizumab 41 S1P antibody 41 translational research 41 FasterCures 41 tezampanel NGX# 41 Leukine ® 41 oral isoform selective HDAC 41 Triapine R 41 MJFF 41 RITUXAN 41 Humanetics 41 PRT# 41 cetuximab Erbitux R 41 ViaCyte 41 AzaSite Plus 41 Solid Tumors 41 AzaSite Xtra 41 Addex Pharmaceuticals Ltd. 41 ENMD # 41 Unibioscreen 41 Okizu 41 YAI NIPD Network 41 trastuzumab DM1 41 Phase Ib study 41 Phase 2b clinical 41 Ontak 41 BCNJ 41 veltuzumab 41 DiabetesAmerica 41 QUMAS 41 BIO 41 ICAAC IDSA 41 Kibow Biotech 41 lenalidomide Revlimid R 41 2 methoxyestradiol 41 intravesical infusion therapy 41 SfN 41 GVAX immunotherapy 41 MAXY alpha 41 monoclonal antibody conjugated 41 IHPM 41 polymerase inhibitors 41 Cancer Therapeutics 41 hematologic malignancies 41 Xcellerex 41 vinorelbine tartrate 41 motesanib 41 gemcitabine chemotherapy 41 ENMD 41 subcutaneous Herceptin 41 WWHI 41 novel peptide 41 ImmuneWorks 41 Profectus 41 ChinaBio ® 41 refractory multiple myeloma 41 APD# 41 nucleoside tide 41 Biological Therapy 41 Lymphoseek ® 41 visit www.pancan.org 41 MEND CABG II 41 Folotyn 41 CELGENE 41 DOS# 41 Genome BC 41 MediciGlobal 41 orally administered inhibitor 41 Micell 41 Tekmira 41 Pediatric Diabetes 41 clofarabine 41 torezolid phosphate 41 ADVEXIN clinical 41 ORE# 41 Amigal 41 radiolabeled TM# 41 NEUVENGE 41 LEP ETU 41 PRECISE trial 41 ASBMR 41 ProLindac 41 Poly ICR 41 BioCrossroads 41 JMP Securities Healthcare 41 isavuconazole 41 recurrent malignant gliomas 41 Symadex 41 Neose 41 Miltenyi Biotec 41 ON #.Na